| Literature DB >> 34765853 |
So Tanaka1,2, Tomohiko Nishigami3, Koji Ohishi4, Kazutaka Nishikawa4, Benedict M Wand5, Tasha R Stanton6, Hirofumi Yamashita7, Akira Mibu8, Masami Tokunaga9, Takaaki Yoshimoto9, Takahiro Ushida2,10.
Abstract
INTRODUCTION: There are complex interactions between pain and perceptions of the painful body part in musculoskeletal disorders, and disruption of various body representations in people with chronic pain.Entities:
Keywords: Body perception; Knee; Osteoarthritis; Swelling; Ultrasonography
Year: 2021 PMID: 34765853 PMCID: PMC8577815 DOI: 10.1097/PR9.0000000000000971
Source DB: PubMed Journal: Pain Rep ISSN: 2471-2531
Figure 1.Quantitative evaluation of effusion in the suprapatellar bursa (objective swelling). (A) The ultrasound scan image of the suprapatellar bursa was acquired by placing a linear probe longitudinally on the suprapatellar pouch. During the examination, the transducers were placed as gently as possible, as pressure on the skin through the transducers can affect the acquired effusion area. Representative images of the suprapatellar swelling area: 30 mm2 (B); 100 mm2 (C).
Sample characteristics.
| S only group (n = 15) | S + O group (n = 15) | No S/O group (n = 16) | Benjamini–Hochberg adjusted | |
|---|---|---|---|---|
| Mean age (y) (SD) | 69.9 (10.4) | 70.2 (7.4) | 66.0 (8.1) | 0.479 |
| Gender (female/male) | 15/0 | 14/1 | 12/4 | 0.360 |
| Pain duration (wk) | 4.5 (1.0–12.0) | 2.5 (1.0–8.0) | 4.9 (1.0–12.0) | 0.361 |
| BMI (SD) | 26.0 (3.5) | 25.5 (1.3) | 25.1 (3.8) | 0.704 |
| Disease severity (K-L grade) | 0.479 | |||
| II | 11 | 9 | 8 | |
| III | 1 | 3 | 6 | |
| IV | 3 | 3 | 2 | |
| Medication (yes/no) | 6/9 | 6/9 | 3/13 | 0.479 |
BMI, body mass index; K-L grade, Kellgren–Lawrence grade.
Comparison of clinical characteristics between groups.
| S only group (n = 15) | S + O group (n = 15) | No S/O group (n = 16) | Benjamini–Hochberg adjusted | Effect size | |
|---|---|---|---|---|---|
| Effusion area (cm2) | 0.37 (0.17 to 0.78) | 1.47 (1.06 to 2.10) | 0.42 (0.10 to 0.95) | <0.001 | η2 = 0.62 |
| FreKAQ (0–36) | 18.3 (4.0 to 33.0) | 19.0 (8.0 to 33.0) | 4.4 (1.0 to 13.0) | <0.001 | η2 = 0.30 |
| Pain intensity (rest) (NRS 0–10) | 2.7 (0 to 6.0) | 2.3 (0 to 8.0) | 0.4 (0 to 3.0) | 0.047 | η2 = 0.12 |
| Pain intensity (motion) (NRS 0–10) | 6.2 (3.0 to 10.0) | 5.1 (1 to 10.0) | 4.7 (1.0 to 8.0) | 0.010 | η2 = 0.15 |
| Disability (OKS 0–48) | 25.7 (14.0 to 40.0) | 28.4 (18.0 to 43.0) | 37.7 (26.0 to 43.0) | <0.001 | η2 = 0.18 |
| TPD threshold: medial (cm) | 4.2 (1.0 to 17.5) | 1.7 (0.5 to 4.0) | 2.8 (0.5 to 7.5) | <0.001 | η2 = 0.17 |
| TPD threshold: lateral (cm) | 4.5 (1.0 to 12.5) | 2.9 (0.5 to 7.5) | 2.6 (0.5 to 7.5) | 0.064 | η2 = 0.11 |
| ROM: flexion (°) | 129.4 (115.0 to 140.0) | 133.3 (105.0 to 145.0) | 137.2 (125.0 to 145.0) | 0.061 | η2 = 0.10 |
| ROM: extension (°) | −8.0 (−15.0 to 0) | −8.3 (−15.0 to 0) | −8.4 (−10.0 to −5.0) | 0.766 | η2 = 0.01 |
| Quadriceps muscle strength (N·m/kg) | 10.7 (6.9 to 21.4) | 14.2 (1.7 to 33.8) | 18.9 (14.2 to 28.5) | <0.001 | η2 = 0.17 |
| PCS (0–52) | 36.4 (21.0 to 45.0) | 24.9 (8.0 to 34.0) | 18.3 (8.0 to 27.0) | <0.001 | η2 = 0.44 |
| PSEQ (0–60) | 32.3 (20.0 to 48.0) | 41.2 (25.0 to 53.0) | 44.4 (36.0 to 56.0) | <0.001 | η2 = 0.28 |
Effect sizes (η2: A large effect was defined as >0.14, a moderate effect as 0.06–0.14, and a small effect as <0.06).
Differences are significant (P < 0.05) compared with the S + O only group.
Differences are significant (P < 0.05) compared with the S only group.
Differences are significant (P < 0.05) compared with the No S/O group.
FreKAQ, Fremantle Knee Awareness Questionnaire; NRS, Numeric Rating Scale; OKS, Oxford Knee Score; PCS, Pain Catastrophizing Scale; PSEQ, Pain Self-Efficacy Questionnaire; ROM, range of motion; TPD, 2-point discrimination.